MARKSANS — Marksans Pharma Share News
0.000.00%
Last trade - 00:00- IN₹130.01bn
- IN₹123.80bn
- IN₹29.51bn
Brief: Marksans Pharma Dec-Quarter Consol Net Profit 832.4 Million Rupees
India's Marksans Pharma hits record high after Q2 profit jump
India's Marksans Pharma up after unit gets UK approval for Vitamin B12 drug
Brief: Marksans Pharma Says Unit Received Marketing Authorisation For Cyanocobalamin Tablets
India's Marksans Pharma rises after US FDA completes inspection at unit
Brief: Marksans Pharma Says Time-Cap Laboratories Got EIR From US FDA
India's Marksans Pharma up on German health authorities' clearance to Goa facility
Brief: Marksans Pharma's Manufacturing Facility Has Undergone Inspection From German Health Authorities
Brief: Marksans Pharma Gets US FDA Approval For Esomeprazole Magnesium Delayed-Release Capsules Usp, 20 Mg (Otc)
India's Marksans Pharma up on FDA nod to anti-cough drug
Brief: Marksans Pharma Receives USFDA Approval For Guaifenesin Extended-Release Tablets
Brief: Marksans Pharma Ltd June-Quarter Consol Net Profit 686.6 Million Rupees
Brief: Marksans Pharma Says FDA Post-Marketing Adverse Drug Experience Inspection Closed With Two Observations
India's Marksans Pharma hits 7-1/2-yr high on US FDA nod for painkiller
Brief: Marksans Pharma Announces FDA Approval For Acetaminophen And Ibuprofen Tablets
India's Marksans Pharma hits nearly 2 yr high as Q4 profit triples
Brief: India's Marksans Pharma March-Quarter Consol Net Profit Rises
India's Marksans Pharma up 3% on manufacturing site acquisition
India's Marksans Pharma rises on USFDA nod for acidity drug